☆ 4.8 Editorial Material

What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?

FRONTIERS IN IMMUNOLOGY (2018)

Journal

FRONTIERS IN IMMUNOLOGY

Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA

DOI: 10.3389/fimmu.2018.01879

Keywords

indoleamine 2; 3-dioxygenase; cancer immunotherapy; p53; metabolism; T-cell

Categories

Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.